Inactive Instrument

Other languages Diffusion Pharmaceuticals Inc Nasdaq

Equities

US2537482067

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Diffusion Pharma : CervoMed Corporate Presentation December 2023	Dec. 20
Diffusion Pharmaceuticals Inc.(NasdaqCM:DFFN) dropped from NASDAQ Composite Index	23-08-17
CervoMed Completes Merger with EIP Pharma	23-08-16
EIP Pharma, Inc. completed the acquisition of Diffusion Pharmaceuticals Inc. in a reverse merger transaction.	23-08-15
Diffusion Pharmaceuticals Shareholders Approve Merger With EIP Pharma; Shares Rise	23-08-15
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma	23-08-15
Diffusion Pharmaceuticals : EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies - Form 8-K	23-08-14
Diffusion Pharmaceuticals : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	23-08-09
Diffusion Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08
Diffusion Pharmaceuticals : EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference - Form 8-K	23-08-03
Diffusion Pharmaceuticals Inc. Appoints Jill Davidson as A Director of the Company, Effective July 26, 2023	23-07-31
DIFFUSION PHARMACEUTICALS INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-06-21
Diffusion Pharmaceuticals Inc. Announces Resignation of William K. Hornung as CFO	23-05-19
DIFFUSION PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-05-15
Diffusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Diffusion Pharmaceuticals : EIP Pharma to Present at JMP Securities Life Sciences Conference - Form 8-K	23-05-11
Top Premarket Gainers	23-04-17
DIFFUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Diffusion Pharmaceuticals Inc. - DFFN	23-03-31
Diffusion Pharmaceuticals, EIP Pharma Agree to Merge to Create New Combined Entity	23-03-30
DIFFUSION PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	23-03-30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Diffusion Pharmaceuticals Inc Nasdaq

Equities

US2537482067

Other languages

Filters